336 related articles for article (PubMed ID: 32769881)
1. Weighted gene coexpression network analysis identifies hub genes related to KRAS mutant lung adenocarcinoma.
Dai D; Shi R; Han S; Jin H; Wang X
Medicine (Baltimore); 2020 Aug; 99(32):e21478. PubMed ID: 32769881
[TBL] [Abstract][Full Text] [Related]
2. Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis.
Dodin Y
Medicine (Baltimore); 2023 Nov; 102(46):e36084. PubMed ID: 37986325
[TBL] [Abstract][Full Text] [Related]
3. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
4. Identification of Six Prognostic Genes in EGFR-Mutant Lung Adenocarcinoma Using Structure Network Algorithms.
Zhang H; Lu D; Li Q; Lu F; Zhang J; Wang Z; Lu X; Wang J
Front Genet; 2021; 12():755245. PubMed ID: 34868228
[TBL] [Abstract][Full Text] [Related]
5. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
7. Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma.
Wang Z; Li X; Chen H; Han L; Ji X; Wang Q; Wei L; Miao Y; Wang J; Mao J; Zhang Z
Med Sci Monit; 2021 May; 27():e929333. PubMed ID: 33979320
[TBL] [Abstract][Full Text] [Related]
8. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases.
Zheng Q; Min S; Zhou Q
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34017995
[TBL] [Abstract][Full Text] [Related]
10. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
[TBL] [Abstract][Full Text] [Related]
11. Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population.
Xie Y; Wu H; Hu W; Zhang H; Li A; Zhang Z; Ren S; Zhang X
Pathol Oncol Res; 2022; 28():1610455. PubMed ID: 36032660
[No Abstract] [Full Text] [Related]
12. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
13. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
15. RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS-mutated lung adenocarcinoma.
Li HS; Liu CM; Wang Y
Thorac Cancer; 2023 May; 14(15):1368-1382. PubMed ID: 37021520
[TBL] [Abstract][Full Text] [Related]
16. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
Dai JJ; Zhou WB; Wang B
Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
Tan J; Wang W; Song B; Song Y; Meng Z
Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
[TBL] [Abstract][Full Text] [Related]
18. Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma.
Chen M; Wang X; Wang W; Gui X; Li Z
Front Immunol; 2022; 13():829057. PubMed ID: 35833114
[TBL] [Abstract][Full Text] [Related]
19. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
[TBL] [Abstract][Full Text] [Related]
20. YTHDF1 Promotes Cyclin B1 Translation through m
Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
